Cargando…
Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors
ERBB2 abnormalities frequently occur and serve as rationale therapeutic targets in cancer. In this study, clinical and next-generation sequencing data from 14,956 patients across more than 20 tumor types were collected. A total of 406 (2.7%) patients were identified with ERBB2 amplifications, and 30...
Autores principales: | Wang, Hao, Miao, Ji, Wen, Yazhou, Xia, Xihua, Chen, Yanan, Huang, Mengli, Chen, Shiqing, Zhao, Zhengyi, Zhang, Yuzi, Chen, Chunzhu, Zhu, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325965/ https://www.ncbi.nlm.nih.gov/pubmed/35911441 http://dx.doi.org/10.3389/pore.2022.1610360 |
Ejemplares similares
-
Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Advanced Biliary Tract Cancer
por: Chen, Chen, et al.
Publicado: (2021) -
Streichquintett D 956
por: Schubert, Franz, 1797-1828
Publicado: (1992) -
Genomic Landscape of Metastatic Lymph Nodes and Primary Tumors in Non-Small-Cell Lung Cancer
por: Chen, Bing, et al.
Publicado: (2022) -
Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics
por: Hu, Boyi, et al.
Publicado: (2022) -
Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes
por: Qi, Wei, et al.
Publicado: (2021)